We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

30 hedge funds and large institutions have $5.36M invested in TriSalus Life Sciences Warrant in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

20% more funds holding

Funds holding: 25 → 30 (+5)

7% less capital invested

Capital invested by funds: $5.77M → $5.36M (-$405K)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
30
Holders Change
+5
Holders Change %
+20%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
2
Reduced
4
Closed
3
Calls
$758K
Puts
–
Net Calls
+$758K
Net Calls Change
+$175K

Top Buyers

1
GL
Governors Lane
New York
+$230K
2
KC
Kepos Capital
New York
+$133K
3
Walleye Capital
Walleye Capital
New York
+$96.6K
4
QGA
Q Global Advisors
Texas
+$66K
5
HF
HRT Financial
New York
+$11.7K

Top Sellers

1
PAMP
Polar Asset Management Partners
Ontario, Canada
-$123K
2
UOC
UBS O'Connor
Illinois
-$56K
3
KJHP
K.J. Harrison & Partners
Ontario, Canada
-$32K
4
BlackRock
BlackRock
New York
-$6.44K
5
MS
Maven Securities
Jersey
-$2.41K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.36M – – –
AGC
2
Angelo Gordon & Co
New York
$947K – – –
AA
3
AQR Arbitrage
Connecticut
$659K – – –
BlackRock
4
BlackRock
New York
$473K -$6.44K -7,016 -0.8%
MF
5
Magnetar Financial
Illinois
$306K +$364 +396 +0.1%
PWAM
6
Park West Asset Management
California
$217K – – –
AC
7
Aristeia Capital
Connecticut
$205K – – –
DM
8
Deerfield Management
New York
$174K – – –
GL
9
Governors Lane
New York
$133K +$230K +250,000 New
LA
10
Linden Advisors
New York
$132K – – –
SCC
11
Spring Creek Capital
Kansas
$87K – – –
VI
12
Vestcor Inc
New Brunswick, Canada
$78K – – –
KC
13
Kepos Capital
New York
$76K +$133K +145,000 New
Point72 Asset Management
14
Point72 Asset Management
Connecticut
$69K – – –
MA
15
MYDA Advisors
New York
$62K – – –
Walleye Capital
16
Walleye Capital
New York
$55K +$96.6K +105,209 New
Balyasny Asset Management
17
Balyasny Asset Management
Illinois
$50K – – –
CH
18
CVI Holdings
Delaware
$43K – – –
SCM
19
Shaolin Capital Management
Florida
$40K – – –
CCM
20
Context Capital Management
California
$37K – – –
QGA
21
Q Global Advisors
Texas
$37K +$66K +71,910 New
ICMH
22
Integrity Capital Management (HK)
Hong Kong
$30K +$52K +56,623 New
MS
23
Maven Securities
Jersey
$25K -$2.41K -2,626 -5%
CM
24
CastleKnight Management
New York
$24K +$42.6K +46,371 New
Jane Street
25
Jane Street
New York
$9K +$227 +247 +1%
1
2

TLSIW Hedge Fund Activity: Q4 2021 in Review

30 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q4 2021, worth a combined $5.36M — down 7% from $5.77M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TLSIW positions and 3 closed out — a net gain of 5 holders — while 2 added to existing stakes and 4 trimmed.

The largest buyer was Governors Lane, opening a new position worth an estimated $230K. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $123K sold.

  • 30 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q4 2021, up from 25 in Q3 2021.
  • Funds reported $5.36M of TriSalus Life Sciences Warrant stock for Q4 2021, down 7% quarter-over-quarter.
  • 8 funds opened new TriSalus Life Sciences Warrant positions in Q4 2021 and 3 closed out, a net change of +5 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q4 2021 was Governors Lane, an estimated $230K added.
  • The largest TriSalus Life Sciences Warrant seller in Q4 2021 was Polar Asset Management Partners, an estimated $123K sold.

Based on aggregated 13F filings for Q4 2021.